Phase 3/Safety & Efficacy of Esomeprazole in Infants

Clinical trial NCT00468559 · COMPLETED

Trial details

NCT number: NCT00468559
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastroesophageal Reflux Disease (GERD)

Start date: 2007-04-01
Primary completion: 2008-06-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.